Alnylam Pharmaceuticals, Inc.(ALNY)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ALNY | 35.71 B | 67.37x | 96.40% | 12.55% | $3.97 | 90.36% | 2.76 | - | $495.55 | $273.11 |
GILD | 166.72 B | 18.27x | 4.40% | 30.99% | $7.35 | 43.36% | 0.95 | 2.60% | $155.38 | $105.01 |
VRTX | 123.26 B | 28.84x | 7.80% | 35.51% | $16.84 | 24.20% | 0.10 | - | $507.92 | $362.50 |
REGN | 69.71 B | 16.52x | 19.00% | 29.65% | $40.97 | 14.55% | 8.61 | 60.00% | $818.90 | $518.16 |
950220.KQ | 8.72 B | - | 38.82% | - | - | -71.12% | 0.20 | - | $7035.00 | $1249.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Alnylam Pharmaceuticals, Inc. (ALNY) compared to its primary competitors (including GILD, VRTX, REGN) reveals distinct metrics. ALNY trades at a valuation premium compared to its competitors, with a P/E ratio of 67.4x versus the peer average of 21.2x (representing a 218% premium). This indicates that the market expects superior growth or commands a quality premium for ALNY. In terms of growth, ALNY's revenue growth of 96.4% exceeds the peer average of 17.5%, highlighting its competitive strength and market share gains. Additionally, its net margin of 12.6% is below the peer average of 32.1%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ALNY ranks #4 in P/E ratio, #1 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $280.99 | $284.36 | $266.43 | $267.47 | 1,378,100 | -4.81% |
| 2026-07-16 | $279.65 | $286.60 | $273.78 | $283.15 | 1,436,200 | +1.25% |
| 2026-07-15 | $281.70 | $284.80 | $275.84 | $279.14 | 1,284,900 | -0.91% |
| 2026-07-14 | $283.55 | $286.76 | $279.43 | $281.26 | 1,093,100 | -0.81% |
| 2026-07-13 | $298.01 | $298.76 | $279.41 | $288.06 | 2,682,700 | -3.34% |
| 2026-07-10 | $314.71 | $322.49 | $293.78 | $298.76 | 2,538,100 | -5.07% |
| 2026-07-09 | $378.49 | $380.00 | $311.10 | $312.79 | 5,864,400 | -17.36% |
| 2026-07-08 | $318.50 | $325.37 | $316.78 | $323.50 | 897,700 | +1.57% |
| 2026-07-07 | $317.07 | $321.98 | $315.35 | $321.59 | 980,400 | +1.43% |
| 2026-07-06 | $319.34 | $319.34 | $307.13 | $313.04 | 891,800 | -1.97% |
| 2026-07-02 | $303.87 | $317.17 | $303.00 | $312.78 | 1,093,400 | +2.93% |
| 2026-07-01 | $304.54 | $309.28 | $301.50 | $301.67 | 1,070,500 | -0.94% |
| 2026-06-30 | $296.82 | $302.74 | $295.18 | $301.03 | 1,411,100 | +1.42% |
| 2026-06-29 | $296.97 | $298.28 | $291.90 | $293.52 | 1,367,300 | -1.16% |
| 2026-06-26 | $297.57 | $302.96 | $290.37 | $291.37 | 1,490,600 | -2.08% |